Document is current
Any future updates will be listed below
-
Authors
Hoehne, Carolin Luisa
Sahin, Aysenur
Overeem, Lucas Hendrik
Lange, Kristin Sophie
Fitzek, Mira Pauline
Angerhöfer, Cornelius
Reuter, Uwe
Raffaelli, Bianca https://orcid.org/0000-0001-9758-1494
- License Information
-
More Information
Article History
Received: 4 June 2025
Accepted: 16 July 2025
First Online: 2 August 2025
Declarations
:
: Carolin Luisa Hoehne, Aysenur Sahin, Lucas Hendrik Overeem and Cornelius Angehöfer have nothing to declare. Kristin Sophie Lange reports a research grant (International Headache Society) and personal fees (Teva, Organon). Mira Pauline Fitzek reports personal fees from Novartis and Teva. Uwe Reuter has no personal fees to report. Institutional fees from Amgen, Abbvie, Lilly, Lundbeck, Novartis, Pfizer, Medscape, Sand Teva, and research funding from Novartis. Bianca Raffaelli reports research grants from Novartis, Lundbeck, German Migraine and Headache Society (DMKG), German Research Foundation (DFG) and Else Kröner-Fresenius-Stiftung, and personal fees from Abbvie, Lundbeck, Novartis, Organon, Perfood and Teva.
: The retrospective data analysis of clinical routine data of headache patients has been approved by the Charité Ethical Committee (EA1/159/22). No specific ethical approval or written informed consent for participation was required for this study in accordance with the national legislation and the institutional requirements, and followed Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for cohort studies [].
